MedPath

MIRAPEXIN 2,1 MG COMPRIMIDOS DE LIBERACION PROLONGADA

MIRAPEXIN 2,1 MG COMPRIMIDOS DE LIBERACION PROLONGADA

Pending
Register Number

97051023IP4

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Jun 26, 2025

Dosage Form

COMPRIMIDO DE LIBERACIÓN PROLONGADA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number97051023IP4
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

PRAMIPEXOLActive
Quantity: 2,1 mg
Name: PRAMIPEXOL

ATC CLASSIFICATION (3)

N04B
N04BC
N04BC05

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.